<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To assess midtrimester uterine artery Doppler in the prediction of <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> and <z:hpo ids='HP_0001518'>small for gestational age</z:hpo> (SGA) infants in women with <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: One hundred seventy pregnant women with histories of <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent miscarriage</z:e> in association with <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (32 lupus <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> positive, 47 IgG anticardiolipin positive, 78 IgM anticardiolipin positive, and 13 lupus <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and anticardiolipin antibodies positive) treated with low-dose aspirin and <z:chebi fb="5" ids="28304">heparin</z:chebi> were recruited prospectively </plain></SENT>
<SENT sid="2" pm="."><plain>Doppler assessment of the uterine arteries (presence or absence of notches and pulsatility index) were performed at 16-18 and 22-24 weeks </plain></SENT>
<SENT sid="3" pm="."><plain>The main outcome measures were the delivery of a SGA infant and the development of <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: There were 164 live births and six midtrimester losses </plain></SENT>
<SENT sid="5" pm="."><plain>The prevalence of <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> and SGA was similar at 10% </plain></SENT>
<SENT sid="6" pm="."><plain>In predicting <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> or SGA, uterine artery pulsatility index at either interval was of no value, and the diagnostic accuracy of the Doppler was limited to bilateral uterine artery notches at 22-24 weeks in the subgroup of women with positive <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>In this subgroup, bilateral uterine artery notches at 22-24 weeks in predicting <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> generated a high likelihood ratio for positive test (12.8, 95% confidence interval 2.2, 75), sensitivity (75%), specificity (94%), positive (75%) and negative (94%) predictive value </plain></SENT>
<SENT sid="8" pm="."><plain>In predicting SGA, the corresponding figures were respectively 13.6 (95% confidence interval 1.9, 96), 80%, 94%, 80%, 94% </plain></SENT>
<SENT sid="9" pm="."><plain>Uterine artery Doppler was of limited value in pregnancies associated with anticardiolipin antibodies in isolation </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: In pregnancies associated with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, uterine artery Doppler at 22-24 weeks is a useful screening test in predicting <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> and SGA infants </plain></SENT>
</text></document>